v3.22.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 9,790 $ 12,360
Short-term investments 17,912 17,327
Receivables 147 47
Prepaid expenses and other current assets 256 466
Total current assets 28,105 30,200
Operating lease right-of-use asset 201 212
Total assets 28,306 30,412
Current liabilities:    
Accounts payable 110 265
Accrued expenses 1,075 1,726
Operating lease liability 47 46
Total current liabilities 1,232 2,037
Operating lease liability, non-current 162 175
Total liabilities 1,394 2,212
Commitments and contingencies (Note 10)
Shareholders’ equity:    
Preferred stock
Common stock, par value $.01 per share; 100,000,000 shares authorized; 30,922,830 and 30,913,902 shares issued and outstanding as of January 31, 2023 and October 31, 2022, respectively 309 309
Additional paid-in capital 248,189 247,123
Accumulated deficit (220,707) (218,385)
Total shareholders’ equity 27,791 29,047
Noncontrolling interest (Note 2) (879) (847)
Total equity 26,912 28,200
Total liabilities and equity 28,306 30,412
Series A Convertible Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock

Source

v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash share-based compensation expenses of $505 and $1,276, respectively) 1,068 1,838
General and administrative expenses (including non-cash share-based compensation expenses of $558 and $1,078, respectively) 1,488 2,042
Total operating costs and expenses 2,556 3,880
Loss from operations (2,556) (3,880)
Interest income 202 1
Net loss (2,354) (3,879)
Less: Net loss attributable to noncontrolling interest (32) (50)
Net loss attributable to common shareholders $ (2,322) $ (3,829)
Net loss per common share attributable to common shareholders:    
Basic and diluted $ (0.08) $ (0.13)
Weighted average common shares outstanding:    
Basic and diluted 30,921 30,125

Source

v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (2,354) $ (3,879)
Stock option compensation to employees and directors 957 2,135
Stock options and warrants issued to consultants 81 219
Common stock issued to consultants 25
Amortization of operating lease right-to-use asset 11 10
Change in operating assets and liabilities:    
Receivables (100)
Prepaid expenses and other current assets 210 (188)
Accounts payable (155) 368
Accrued expenses (651) 147
Operating lease liability (12) (9)
Net cash used in operating activities (1,988) (1,197)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (7,835) (3,499)
Proceeds from maturities of short-term investments 7,250 5,349
Net cash provided by (used in) investing activities (585) 1,850
Cash flows from financing activities:    
Proceeds from exercise of stock options 3
Net cash provided by financing activities 3
Net increase (decrease) in cash and cash equivalents (2,570) 653
Cash and cash equivalents at beginning of period 12,360 29,128
Cash and cash equivalents at end of period $ 9,790 $ 29,781

Source